Orthofix Medical Inc.
OFIX
$16.09
-$0.05-0.31%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.59% | 2.27% | 2.67% | 7.61% | 6.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.59% | 2.27% | 2.67% | 7.61% | 6.85% |
| Cost of Revenue | -7.22% | -0.44% | 17.37% | 12.37% | -4.19% |
| Gross Profit | 9.97% | 3.55% | -4.42% | 5.72% | 12.77% |
| SG&A Expenses | 13.84% | 1.70% | 0.98% | 3.17% | 6.35% |
| Depreciation & Amortization | -31.44% | -10.33% | -53.73% | 0.49% | 4.14% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.49% | -0.26% | 3.97% | 5.23% | 1.90% |
| Operating Income | -3.27% | 23.22% | -11.99% | 34.83% | 34.14% |
| Income Before Tax | 16.42% | 56.05% | -48.24% | -34.75% | 6.16% |
| Income Tax Expenses | -29.03% | -113.10% | 12.93% | -551.20% | 59.11% |
| Earnings from Continuing Operations | 16.77% | 57.90% | -47.40% | -31.44% | 5.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.77% | 57.90% | -47.40% | -31.44% | 5.09% |
| EBIT | -3.27% | 23.22% | -11.99% | 34.83% | 34.14% |
| EBITDA | -1,766.67% | 119.55% | 110.70% | 284.62% | 101.45% |
| EPS Basic | 19.45% | 59.47% | -41.96% | -26.68% | 8.15% |
| Normalized Basic EPS | 11.07% | 50.76% | 0.81% | -74.88% | 19.20% |
| EPS Diluted | 19.45% | 59.09% | -41.96% | -26.68% | 8.15% |
| Normalized Diluted EPS | 11.07% | 50.76% | 0.81% | -74.88% | 19.20% |
| Average Basic Shares Outstanding | 3.32% | 3.90% | 3.83% | 3.75% | 3.33% |
| Average Diluted Shares Outstanding | 3.32% | 3.90% | 3.83% | 3.75% | 3.33% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |